Founded in 2006, Affinity Biosciences is a pioneering Life Science and High-Tech company whose biochemical products and services are mainly applied in biotechnology, medical research and pharmaceutical development.
Dedicating to advancing customer success through innovation, Affinity Biosciences has established R&D affiliates in the United Kingdom and United States with the aim of providing outstanding service around the globe. Affinity Biosciences customers include scientists and technologists in life science companies, university and government institutions, hospitals and industry. To underline the commitment to the customers and enhance the standards of service, they have opened packaging and quality control facilities in the People’s Republic of China. Affinity Bioscience's goal is to develop high-quality antibody that focuses on Cell Signaling Transduction research, including Akt,AMPK,NF-KappaB,TGF-beta,etc,as well as inhibitors and related reagents.